Pay in 4 interest-free payments of $5.56 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
Targeting POLRMT by IMT1 inhibits colorectal cancer cell growth
(2022) demonstrated Cerebrolysin's effects on Alzheimer's disease biomarkers in a randomized controlled trial, providing objective biological evidence for its neurotrophic activity (PMID: 36155516) Regulatory Validation: Approved for clinical use in over 40 countries for indications including stroke, traumatic brain injury, and dementia (though not FDA-approved in the United States) Dihexa: Preclinical Only, with Integrity Concerns Dihexa's evidence base is entirely preclinical and has faced significant scientific integrity challenges: Foundational Research: Wright et al
The maximal activity of the dimeric macrocycles was observed at around 100 nM
Estrogens and Dermal Collagen Research indicates estrogen influences collagen density and dermal structure, particularly in peri- and postmenopausal women
Int J Cosmet Sci
US$ 29.14
US$ 23.06
US$ 22.73
US$ 28.57
US$ 28.24
US$ 27.67
US$ 24.47
US$ 22.22
US$ 26.28
US$ 21.52
US$ 28.21
